Trial Profile

A Prospective, Randomized, Double Blind, Parallel Group Study to Establish the Therapeutic Equivalence of EPIAO With the Standard Treatment EPREX in Subjects With Chronic Kidney Disease (CKD) Related Anaemia Not Yet on Dialysis

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 17 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 Oct 2020 Status changed from recruiting to discontinued.
27 Apr 2018 Planned End Date changed from 1 Aug 2018 to 1 Aug 2019.
27 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com